Signals
Alzheimer’s Pill Has Finished the Trial. Evidence Has Not.
AriBio’s POLARIS-AD Phase III trial of AR1001 has completed its 52-week treatment phase. The safety update is useful, but the result that matters is still coming.
India’s Obesity Campaign Dispute Tests the Line Between Awareness and Promotion
Cyberbullying Becomes a Youth Mental Health Policy Target
Rare Epilepsy Moves Toward Treating the Cause
Digital Mental Health Still Has an Evidence Problem
Europe’s Mental Health Projects Move From Crisis Talk to Delivery Tools
Europe’s Epilepsy Rules Start Catching Up With Precision Treatment
SMA Screening Shows Precision Neurology Starts Before Symptoms
Post-Stroke Cognitive Screening Needs Local Tools
Europe’s Stroke Plan Turns Speed Into a Policy Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.